You are currently viewing a new version of our website. To view the old version click .
Clinics and Practice
  • Clinics and Practice is published by MDPI from Volume 11 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with PAGEPress.
  • Case Report
  • Open Access

7 November 2018

Acute Tubulointerstitial Nephritis and Polyclonal Hypergammaglobulinaemia: Which Is the Culprit?

,
,
,
,
,
,
and
1
Nephrology Section, Hospital General Universitario de Elche, Spain
2
Pathology Section, Hospital General Universitario de Elche, Spain
3
Diagnostic Radiology Service, Hospital General Universitario de Elche, Spain
4
Ophthalmology Section, Hospital General Universitario de Elche, Spain

Abstract

Proton pump inhibitors (PPIs) are among the most frequent implicated drugs in acute tubulointerstitial nephritis (ATIN), nevertheless it is important to report cases with atypical profiles. A 80-year-old female, exposed during 34 months to omeprazole, presented with polyclonal hypergammaglobulinaemia and renal failure. After stopping omeprazole there was a partial improvement in serum creatinine and IgG. Renal biopsy revealed ATIN; immunohistochemistry for IgG4 was negative. Treatment with steroids and mycophenolate sodium improved renal function and normalized immunoglobulins. The lack of data of other entities and the patient’s evolution strongly point omeprazole as the culprit. After 27 months of follow-up, she remains clinical and analytically stable. ATIN caused by PPIs may appear after a long period of exposure and may be accompanied by analytical anomalies that simulate a systemic disease.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.